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Farm  animals  remain  at risk  of  endemic,  exotic  and  newly  emerging  viruses.  Vaccination
is often  promoted  as the best  possible  solution,  and  yet  for many  pathogens,  either  there
are no appropriate  vaccines  or those  that  are  available  are far from  ideal.  A complementary
approach  to  disease  control  may  be  to  identify  genes  and  chromosomal  regions  that underlie
genetic variation  in disease  resistance  and  response  to  vaccination.  However,  identiﬁcation
of the  causal  polymorphisms  is  not  straightforward  as  it generally  requires  large  numbers  of
animals with  linked  phenotypes  and  genotypes.  Investigation  of  genes  underlying  complex
traits  such  as  resistance  or response  to viral  pathogens  requires  several  genetic  approaches
including  candidate  genes  deduced  from  knowledge  about  the  cellular  pathways  leading
to protection  or  pathology,  or unbiased  whole  genome  scans  using  markers  spread  across
the genome.
Evidence for  host  genetic  variation  exists  for a  number  of viral  diseases  in  cattle  includ-
ing  bovine  respiratory  disease  and  anecdotally,  foot  and  mouth  disease  virus  (FMDV).
We  immunised  and  vaccinated  a cattle  cross  herd  with  a 40-mer  peptide  derived  from
FMDV  and  a  vaccine  against  bovine  respiratory  syncytial  virus  (BRSV).  Genetic  variation
has been  quantiﬁed.  A  candidate  gene  approach  has  grouped  high  and  low  antibody  and
T cell  responders  by  common  motifs  in  the  peptide  binding  pockets  of the  bovine  major
histocompatibility  complex  (BoLA)  DRB3  gene.  This  suggests  that  vaccines  with  a  minimal
number  of  epitopes  that are  recognised  by most  cattle  could  be designed.  Whole  genome
scans using  microsatellite  and  single  nucleotide  polymorphism  (SNP)  markers  has  revealed
many novel  quantitative  trait loci (QTL)  and SNP  markers  controlling  both  humoral  and
cell-mediated  immunity,  some  of  which  are  in genes  of  known  immunological  relevance
including  the  toll-like  receptors  (TLRs).
The sequencing,  assembly  and  annotation  of  livestock  genomes  and  is  continuing  apace.
In addition,  provision  of  high-density  SNP  chips  should  make  it possible  to link phenotypes
with  genotypes  in  ﬁeld  populations  without  the need  for structured  populations  or  pedigree
information. This  will  hopefully  enable  ﬁne  mapping  of  QTL  and  ultimate  identiﬁcation  of
the causal  gene(s).  The  research  could  lead  to  selection  of animals  that  are  more  resistant
to disease  and  new  ways  to improve  vaccine  efﬁcacy.∗ Corresponding author. Tel.: +44 131 651 9100; fax: +44 131 651 9105.
E-mail address: liz.glass@roslin.ed.ac.uk (E.J. Glass).
165-2427/     ©  2011 Elsevier B.V. 
oi:10.1016/j.vetimm.2011.05.009
Open access under CC BY license.© 2011 Elsevier B.V. 
1. Genetic variation in disease resistance and
vaccine response
Open access under CC BY license.Endemic and exotic pathogens continue to have a
signiﬁcant effect on livestock with high economic costs
and  welfare implications worldwide. In addition emerging
pathogens are increasingly recognised as a threat to
gy and IE.J. Glass et al. / Veterinary Immunolo
biosecurity and zoonotic pathogens and chemical usage
still cause food safety hazards. These concerns remain
despite increasing regulation and control measures such
as  good management and the availability of vaccines
at least to some pathogens. Globalisation of trade and
climate change bring new urgency to ﬁnd ways to reduce
the  impact of infectious disease which remains a barrier
to  further improvement in livestock efﬁciency in both the
developed and developing world.
One potential solution is to breed livestock that
are inherently more resistant or tolerant to prevailing
pathogens. However it is not easy to identify markers and
genes  that would enable selection of such desirable traits,
partly  because of the cost and logistics of collecting appro-
priate  large-scale data either from the ﬁeld or experimental
challenges. Thus there is a phenotype gap. Furthermore
resistance or tolerance traits are likely to be underpinned
by many genes of small effect, making it more difﬁcult to
identify  them. Another solution would be to design more
effective vaccines. After the foot and mouth disease virus
(FMDV) outbreak in the U.K. in 2001, the Royal Society
stated that research should concentrate on developing an
ideal  vaccine that would be “safe, synthetic, induce ster-
ile  immunity, in one shot, be cost effective and protect all
animals”  (Royal Society, 2002). It is debatable whether any
livestock  vaccine would meet all of these criteria. In addi-
tion  for many diseases there are no appropriate vaccines.
Generally, most research into vaccines has focused on
the  pathogens and the identiﬁcation of pathogen-encoded
vaccine candidates, and less on the host response. Yet, in
most  vaccine studies, evidence of variation in response
has been reported, with varying proportions of non-
responders, even after several immunisations, as well as
individuals with adverse reactions. However this varia-
tion  has mainly been ignored, or considered as inevitable
animal-to-animal variation. On the other hand this sug-
gests  that at least some of the observed variation may
be  genetic and understanding what leads to non- or low-
response, or pathology at the other extreme might identify
new  targets both for immunomodulators as well as for
immunotherapeutics. These genes may  also highlight new
pathways  that regulate the response to pathogens and be
of  more general importance. Genetic variability in response
to  vaccination is likely to become an even more signif-
icant factor in designing ideal “safe, synthetic” vaccines.
The genes identiﬁed might also be important for disease
resistance traits, and could potentially provide the tools
to  select “good responders”, as originally suggested by
Wilkie  and Mallard (1999) and more recently by Gay et al.
(2007).  However, the genes underlying variation in vaccine
response have not been greatly explored in either humans
(Poland et al., 2008) or livestock (Glass, 2004).
Probably the most complex issue in aims to identify
genes controlling disease resistance or vaccine response
relates to the choice of phenotype(s). Depending on the
pathogen, the goal may  be to prevent infection completely
or  more likely to reduce the consequences of infection,
particularly those that impact on performance traits
such as growth, milk and meat quality. Although it has
been  reported that selecting for performance has had
a  detrimental effect on resistance to infectious disease,mmunopathology 148 (2012) 90– 99 91
for  example milk yield and mastitis (Heringstad et al.,
2005),  the relationship between performance and disease
resistance can show beneﬁcial correlations. Susceptibility
to Mycobacterium bovis is negatively genetically correlated
with  milk yield (Brotherstone et al., 2010) as well as
survival (Bermingham et al., 2010) and susceptibility to
M.  avium subspecies paratuberculosis (MAP) is negatively
correlated with several productivity traits including a
combined productivity score, Net Merit (Attalla et al.,
2010). Although these results need conﬁrmation in other
populations, they would suggest that selection for disease
resistance and improved performance is a realistic goal.
Furthermore the livestock industry routinely selects for
a  number of different criteria using a selection index of
weighted traits (for example, Haile-Mariam et al., 2010).
Thus,  it should be possible to incorporate both disease
resistance and performance as goals for selection. How-
ever,  identifying relevant phenotypes for both infectious
disease resistance and vaccine response is not straight-
forward, as in many cases the correlates of protection are
unclear  and/or difﬁcult to measure.
We have undertaken a number of approaches to begin to
address  the hypothesis that small sequence changes (poly-
morphisms) in key host immune response genes, results in
much  greater changes in immune outcome. The ﬁrst steps
in  trying to identify these genes is to determine if there is in
fact  any variation in phenotype – in this case in vaccine or
immune  responsiveness –and  if so, to determine if any phe-
notypic  variance can be accounted for by genetics. Usually
this  involves a large number of animals and linked pheno-
types, in which the observed variation is partitioned into
“environmental effects” (i.e. year of sampling, farm, etc.)
and  genetic effects (i.e. sire, line, breed, etc.) using mul-
tivariate statistical methods such as restricted maximum
likelihood (REML) methods. The proportion of variance in
the  population being tested attributed to genetic factors
is  referred to as “heritability” or “h2
′′
. In general, most
disease resistance studies based on ﬁeld studies report rela-
tively  low heritability e.g. mastitis studies typically report
h2 ∼ 0.05 (Rupp and Boichard, 2003). However, these are
likely  to be underestimates as they are often based on treat-
ment  records or outcome at slaughter and are thus not very
accurate.  They are also based on all animals in a study and
it  is often unknown whether all the animals were exposed
or  not. This is particularly important as in many cases the
resistance or tolerance phenotype is only expressed fol-
lowing  exposure. Thus low estimates of heritability should
not  necessarily be viewed as a stumbling block to further
investigation (Bishop and Woolliams, 2010). In addition
heritability depends on the population and its environ-
ment, and does not describe the nature of the underlying
genes, their number or impact on phenotype.
Generally, once variation has been established, two
main types of study in which the phenotype is correlated
with the genotype are undertaken. These involve linkage
(in  which the phenotypes are linked to markers inherited
within family groups) or association (in which unrelated
individuals are divided according to phenotype and the
frequencies of markers within each group are compared).
Investigation into the complexities of immune or vac-
cine  responsiveness can take complementary approaches:
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ither candidate genes previously determined by knowl-
dge  of mechanisms leading to protection or pathology, or
hole  genome approaches which do not rely on a priori
iscoveries and use markers distributed across the entire
enome. In the past, association studies have mainly relied
n  candidate gene polymorphisms, whereas whole genome
tudies  have employed linkage analysis with microsatellite
arkers to identify chromosomal regions that affect the
henotype: so called quantitative trait loci (QTL). Only a
imited  number of studies in livestock have identiﬁed QTL
or  disease resistance and even fewer for immune/vaccine
esponse. Until recently, these have mainly involved a
elatively limited number of microsatellite markers, and
he  chromosomal regions identiﬁed as having signiﬁcant
mpact on the traits have been very broad and contained
arge numbers of candidate genes. However with the
dvent of livestock genome sequences and identiﬁcation
f very large numbers of single nucleotide polymorphisms
SNPs), it is now possible to conduct association analyses
ith thousands of SNPs as markers spread across genomes
hich should make it easier to identify causal genes
reviewed by Fan et al., 2010). For example, using the Illu-
ina  Bovine 50 Bead chip which contains approximately
0,000 SNPs, several studies have recently reported multi-
le  loci controlling infection with or antibody response to
AP  (Settles et al., 2009; Minozzi et al., 2010; Pant et al.,
010;  Kirkpatrick et al., 2011). However, there is only lim-
ted  concordance between the studies in terms of identiﬁed
oci,  some of which may  relate to differences in MAP  trait
eﬁnitions. Higher density SNP arrays are now available
or  cattle containing over ten times the number of SNPs in
he  Illumina Bovine 50 Bead chip which in theory means
hat  details of pedigree structures are probably no longer
ecessary, and should make genetic studies more tractable
or  livestock. Nonetheless although there has been con-
iderable investment in the technology and resources for
arge-scale genotyping in cattle and other domestic species,
he  issues surrounding the “phenotype” gap remain to be
olved.
Control  of viral pathogens poses particular problems
or livestock management because of their very nature.
heir ability to proliferate, mutate and to modulate the host
mmune  response might suggest that host species could not
volve  counter-measures fast enough to become resistant,
et  there is considerable evidence indicating that genes
nvolved in host defence are extremely diverse both within
nd  between species (Barreiro and Quintana-Murci, 2010).
vidence  for host genetic variation exists for viral diseases
n  many host species including cattle (Glass et al., 2010)
nd  the remainder of this article will focus on the genet-
cs  of bovine respiratory disease and vaccine responses in
attle.
.  Bovine respiratory disease
Bovine respiratory disease (BRD) is a major welfare and
conomic burden affecting both beef and dairy cattle, and
osting  around $750 million per annum in the United States
Snowder et al., 2006; Miles, 2009). BRD is a complex of
iseases  with many viral and bacterial infectious agents.
he  most common viral pathogens which are known tommunopathology 148 (2012) 90– 99
contribute  to the development of BRD include bovine res-
piratory  syncytial virus (BRSV), parainﬂuenza virus (PIV)-3,
bovine  herpes virus (BHV)-1 and bovine viral diarrhoea
virus (BVDV) (Fulton, 2010). Often infection with viral
respiratory pathogens results in secondary bacterial infec-
tions,  including Mannheimia haemolytica, Histophilus somni
and  Pasteurella multocida (Grifﬁn et al., 2010). Currently
the control methods for BRD include good management,
antibiotics and vaccination against the viral pathogens,
BHV-1, BVDV, BRSV and PIV-3 (Bowland and Shewen, 2000)
as  well as vaccination against the bacterial pathogens, M.
haemolytica and P. multocida associated with BRD (Fulton,
2010),  although the efﬁcacy of these vaccines has mainly
not  been subject to controlled challenge studies (Bowland
and  Shewen, 2000). The pathogens involved in BRD have
co-evolved with their hosts and developed strategies for
manipulating and evading the host immune response and
this  enables these pathogens to persist, and may  be at least
partly  responsible for the failure of current vaccines to con-
trol  BRD (Srikumaran et al., 2007).
A number of studies have indicated that different
breeds of cattle have different degrees of susceptibility
to BRD and heritability has been estimated to be around
0.04–0.08 (Muggli-Cockett et al., 1992; Snowder et al.,
2005,  2006, 2007; Heringstad et al., 2007). It is possible that
susceptibility to BRD is greater than estimated for the rea-
sons  described above, especially as the speciﬁc pathogens
causing BRD are often unknown. In any case the genes
underlying any genetic differences between animals or
breeds  are unknown.
3.  Bovine respiratory syncytial virus
One of the major pathogens causing BRD as well as
bovine shipping fever is considered to be BRSV which is a
large  enveloped, negative sense single stranded RNA Pneu-
movirus  of the Paramyxoviridae family. It is ubiquitous in
both  dairy and beef cattle worldwide. Different strains
of  RSV also infect sheep, goats and humans. The clinical
signs of BRSV include severe infection of the lower res-
piratory tract, resulting in coughing and nasal discharge
and abnormal breathing sounds (Antonis et al., 2003).
However, its effect on the host is variable from mild to
severe; BRSV causes high morbidity in young animals and
is  the most important cause of lower respiratory tract
infection in young calves (Valarcher and Taylor, 2007).
By  nine months of age over 70% of calves are estimated
to have been infected with BRSV. Intensiﬁcation of farm-
ing  has probably increased the prevalence of BRSV in
livestock. Thus this pathogen alone has high economic
impact.
Currently the control of BRSV infection is mainly
through management practices that reduce the level of cir-
culating  pathogen as well vaccination with modiﬁed live
virus  (MLV) or killed virus vaccines (Meyer et al., 2008).
However, there is little concensus about which vaccines
are the most efﬁcacious as most studies conducted have
been  experimental trials and there are few ﬁeld studies
demonstrating clinical protection or reduction in clinical
disease with any BRSV vaccine (Meyer et al., 2008). One of
the  most common MLV  vaccines used in Europe is Rispoval
gy and IE.J. Glass et al. / Veterinary Immunolo
RS (Pﬁzer) which is based on strain RB-94 (1969 Belgian
isolate) (Zygraich, 1982).
Infection with BRSV, as with its human counterpart,
HRSV, does not induce long lasting immunity (Meyer et al.,
2008)  and often calves are repeatedly infected before they
become  essentially immune to further infection. Similarly
BRSV  vaccines have limited protective capacity. Further-
more calves are particularly at risk as maternal antibody
begins to wane. Yet, it is clear that this passively acquired
antibody inhibits responses induced by vaccination (O’Neill
et  al., 2007; Meyer et al., 2008) and clearance of antibody is
variable  and at least in part genetically determined (O’Neill
et  al., 2006), making the timing of effective vaccination dif-
ﬁcult  to achieve. It is generally considered that neutralising
antibody is the most important protective mechanism, and
particularly  mucosal antibody, but the precise role of dif-
ferent  subclasses of immunoglobulin, in clearance of virus,
maintenance of protection and induction of pathology is
less  clear (Meyer et al., 2008). In cattle, as in mice and
humans, it appears that protection is associated with both
a  Th1 type response involving interferon- (IFN-) as well
as  the corresponding IgG subclass, IgG2 (Mapletoft et al.,
2006),  and a Th2 type response involving IgG1 (Kalina et al.,
2005).  BRSV infection induces bovine major histocompati-
bility complex (MHC) (BoLA) class II restricted CD4+ and
BoLA  class I restricted CD8+ T cells (Taylor et al., 1995;
Gaddum et al., 1996; Fogg et al., 2001) and depletion of T
cells  in the respiratory tract leads to delayed BRSV clear-
ance  in calves (Taylor et al., 1995), suggesting that cell
mediated immunity must also be important for protection
in  cattle.
Although BRSV is cytopathic in vivo and is associated
with pathology involving innate and adaptive immune
cells, in vitro, cell death does not necessarily occur and
depends on the cell type infected (Valarcher and Taylor,
2007). Furthermore, pathology does not correlate with viral
load  (Gershwin, 2007). These ﬁndings suggest that the
pathology seen in cattle is related more to the host immune
response than to the virus (Gershwin, 2007; Ellis, 2009).
There  are no licensed vaccines for human RSV, partly
because formalin inactivated vaccines administered to
babies,  resulted in higher levels of pathology following nat-
ural  infection with HRSV (Meyer et al., 2008). It has been
suggested that these vaccines induced a non-protective
Th2 biased response and that this was then invoked by nat-
ural  infection and caused the observed pathology (Meyer
et  al., 2008). Similarly, experimental administration of
inactivated BRSV vaccines can result in pathology following
challenge with live BRSV, which appears to be medi-
ated by an exacerbated Th2 mediated response including
eosinophilia and IgE and suppressed IFN- (Th1) response
(Gershwin, 2007). Nonetheless, these type of vaccines for
cattle  have been in use for many years and generally not
found  to result in such disease enhancement (Meyer et al.,
2008).  Thus it currently remains difﬁcult to draw ﬁrm con-
clusions  about the likelihood of inactivated BRSV vaccines
inducing protective or pathogenic responses to natural
BRSV infection. As with all BRSV vaccine responses, it seems
likely  that both vaccine and host factors such as strain of
BRSV,  dose, differences in adjuvants, maternal antibody
and  age, may  account for some of the variation betweenmmunopathology 148 (2012) 90– 99 93
animals and experimental studies. However, the role of
host  genetics in BRSV vaccine induced pathology and pro-
tection  in cattle has up to now not been explored.
4. The role of genetics in determining the outcome
of BRSV infections and vaccination
Although a role for genetics in variability in clinical out-
come  for RSV infection has been evinced in human studies
(Janssen et al., 2007; Miyairi and DeVincenzo, 2008; Glass
et  al., 2010), such evidence is lacking for cattle and BRSV.
However as the pathology in BRSV and HRSV shows many
similarities, it seems likely that genetics must play a role
(Glass  et al., 2010). Furthermore, the evidence of genetics
playing a role in BRD (see above) and the strong correlation
of  seropositivity for BRSV with BRD might also indicate a
role  for genetics in the bovine response to natural infection
with  BRSV. In addition, variation in the clearance of circu-
lating  maternal antibody was  also shown to have a genetic
component (O’Neill et al., 2006).
In contrast to the genetics of natural infection with
BRSV, the response to vaccination with a MLV  BRSV vaccine
(Rispoval RS) has been linked to genetics. BRSV-speciﬁc
IgG1 and IgG2 levels were measured prior to and follow-
ing  vaccination of approximately 500 young calves, and
found  to be highly variable between animals. These param-
eters  were chosen as potential indicators of Th2 and Th1
responses in cattle respectively (Estes and Brown, 2002)
as  it has been hypothesised that genetic control of these
pathways may  underlie susceptibility and resistance to
many  pathogens. Furthermore both isotypes appear to be
important  for protection against BRSV (Kalina et al., 2005;
Mapletoft et al., 2006). Heritabilities for serum IgG1 and
IgG2  responses to vaccination were estimated to be as high
as  0.36 at day 35 following vaccination, and signiﬁcant sire
effects  were also discovered (O’Neill et al., 2006). This study
exploited an experimental second generation cross popula-
tion  of dairy (Holstein) and beef (Charolais) cattle for which
pedigrees were established. This population was  also geno-
typed  for 165 microsatellite markers and also for BoLA class
II  DRB3 alleles by a modiﬁed sequence based typing method
of  the polymorphic second exon of DRB3 (Baxter et al.,
2008).  QTL studies on production related traits on this pop-
ulation  have revealed many QTL (Gutierrez-Gil et al., 2007,
2008a,b,  2009, 2010), and in addition several immune-
related studies have now been carried out. In addition to
the  BRSV study (O’Neill et al., 2006), a genetic component to
the  T cell response to a mastitis causing pathogen, Staphy-
lococcus aureus, has been reported (Young et al., 2005).
Furthermore, following immunisation of this herd with a
40-mer  peptide derived from foot-and-mouth disease virus
(FMDV),  a large number of QTL (Leach et al., 2010) and
BoLA  DRB3 polymorphisms (Baxter et al., 2009) have been
associated with antibody responses to this peptide.
We  have now found that, as with the response to the
FMDV peptide (Leach et al., 2010), many regions of the
bovine genome are strongly associated with the levels pre-
and  post-vaccination with the BRSV vaccine (summarised
in Table 1). The variance in the phenotypic traits (total BRSV
speciﬁc  IgG, BRSV speciﬁc IgG1 and BRSV speciﬁc IgG2)
explained by each QTL was  around 2–3%. It can be seen that
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Table  1
The  sequential inﬂuence of signiﬁcant quantitative trait loci (QTL) associated with BRSV speciﬁc antibody levels pre- and post-vaccination across time.
Daya/Traitb Chromosome number (BTAc)
3 17 2 10 15 8 18 7 9 23 24 14
Pre-vaccination
−14 Xd XX X
0: Totale IgG X
0: IgG1 X X
0:  IgG2 X
Post-vaccination
0–14 X X X
14: Total IgG X X
I4:  IgG1 X
14: IgG2 X X X X X X
0–49  X
49: Total IgG X X X
49:  IgG1 X
Overallf IgG1 X X
Overall IgG2 X
a Day is relative to vaccination at day 0.
b Trait = BRSV speciﬁc antibody level, measured by ELISA as detailed in (O’Neill et al., 2006).
c BTA = Bos taurus autosome. The order shown attempts to reﬂect the inﬂuence of different QTL across the time course, with those loci which inﬂuence
the  response at the earliest time point being shown ﬁrst.
d esents two QTL on the same chromosome.
e (calculated as “area under the curve” by the Trapezoidal rule). All QTL are at
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Table 2
Signiﬁcant BoLA DRB3 alleles associated with BRSV-speciﬁc IgG levels pre-
and  post-vaccination.
DRB3 allelea Pre-vaccination Post-vaccination
*0801 <0.05b N.S.
*0901 N.S.c <0.05
*1002  N.S. <0.05
*1701  N.S. <0.05
a DRB3 alleles determined by a sequence based typing method of the
pre-vaccination and post-vaccination levels of anti-BRSV
antibody (Table 2), there were very few animals in the herd
that  carried these alleles and the results must be treated
with caution, and require veriﬁcation in other populations.
Table 3
Peptide binding pockets signiﬁcantly associated with BRSV-speciﬁc IgG
levels  pre- and post-vaccination.
DRB3 Pocketa Pocket position Pre-vaccination Post-vaccination
4 13 <0.05b N.S.c
4 70 N.S. <0.05
4  74 N.S. <0.001
7  28 N.S. <0.05
7  30 N.S. <0.05Each X represents the presence of a signiﬁcant QTL (p < 0.05); XX repr
e Total refers to IgG1 and IgG2 levels.
f Overall refers to the total amount of IgG isotype generated across tim
east  5% chromosome wide signiﬁcant
ome chromosomal regions (on BTA 10 and 15) only inﬂu-
nced  the clearance of maternally derived antibody and not
he  response to vaccination whereas others (on BTA 7, 8, 9,
4,  18, 23 and 24) only inﬂuenced the response to vacci-
ation and not the level of antibody prior to vaccination.
nly two chromosomes (BTA 2 and 17) harboured genes
hat  inﬂuenced the level of antibody both pre- and post-
accination. Interestingly, the level of variation of IgG2 at
4  days post vaccination appears to be the most polygenic
rait, with six different chromosomal regions signiﬁcantly
ssociated with this trait, in contrast to the variation in
he  IgG1 levels at the same time point, where only a sin-
le  QTL was detected. Since IgG1 and IgG2 are believed to
e  controlled by Th2 and Th1 cells, respectively (Estes and
rown,  2002), these results suggest that these pathways
re inﬂuenced by different genes. It is also apparent that
he  early and later responses to vaccination are controlled
y  different genes. It is worth noting that the QTL on BTA23
hilst they have broad conﬁdence intervals, do cover the
ovine  MHC  region suggesting that the bovine MHC may
e  involved in determining the level of antibody response
o  the BRSV vaccine (and see below).
In almost every immune-related study for which there
s  evidence for a genetic component, the MHC  has been
dentiﬁed as playing a role (Glass, 2004). Given the likely
mportant role for cell mediated immunity in BRSV infec-
ion,  including CD4+ and CD8+ Tells (Taylor et al., 1995),
t  would seem likely that polymorphisms in MHC  genes
ould affect both the outcome from infection and also vac-
ination.  However, although many candidate genes have
een  associated with outcome of HRSV infection in human
tudies, none have reported MHC  associations for human
r  bovine RSV infection or vaccination (Janssen et al., 2007;
iyairi  and DeVincenzo, 2008; Glass et al., 2010), although
 very recent study in congenic strains of mice has shown
hat  MHC  haplotypes play a role in the susceptibility of2nd exon of BoLA DRB3, as described in Baxter et al. (2008).
b p values determined by Wald test.
c N.S. = not signiﬁcant.
neonatal mice (Tregoning et al., 2010). We have now dis-
covered  a number of signiﬁcant associations between BoLA
class  II DRB3 polymorphisms and both the circulating level
of  antibody prior to vaccination as well as the antibody
response to the BRSV vaccine (Tables 2 and 3). Although
a  few DRB3 alleles were signiﬁcantly associated with both9  37 <0.05 N.S.
a DRB3 Pockets determined as described in Baxter et al. (2009).
b p values determined by Wald test.
c N.S. = not signiﬁcant.
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However, the majority of polymorphisms found in MHC
class  II DRB genes are concentrated in exon 2 and par-
ticularly in the sequences encoding the peptide binding
pockets. These are the major binding anchors for presented
peptides. Thus BoLA DRB3 alleles can be grouped into a
series  of peptide binding pocket motifs (Sharif et al., 2000;
Baxter  et al., 2009). Several individual positions within
three of these pockets were signiﬁcantly associated with
the  pre- and post-vaccination antibody levels to BRSV
(Table 3). It is striking that none of the associations were
signiﬁcant for both the pre- and post-vaccination BRSV spe-
ciﬁc  antibody levels. Perhaps not surprisingly this suggests
that  the rate of clearance of maternal antibody is con-
trolled by different mechanisms from those operating in
the  induction of an adaptive response. The relative paucity
of  signiﬁcant associations reported here are in marked
contrast to those found with the FMDV peptide (Baxter
et  al., 2009) where several alleles and pocket positions were
highly  signiﬁcantly associated with response. There are
likely  to be many reasons for this, not least that the FMDV
40-mer peptide has a limited number of epitopes whereas
BRSV  is likely to have many different epitopes recognised
by the host immune system. In addition, the BRSV anti-
body  levels are confounded with the pre-vaccination levels
of  circulating antibody. Nonetheless it is interesting that
the  pocket with the greatest associations was pocket 4 and
this  mirrors the ﬁndings with the FMDV peptide response
(Baxter et al., 2009). Pocket 4 is located centrally within
the  peptide binding groove of DR molecules and has been
implicated as playing a signiﬁcant role in human immune
responsiveness (Ou et al., 1998). This might indicate that in
terms  of vaccine design for any pathogen, ensuring that the
vaccine  includes epitopes that bind strongly to the major
pocket 4 variants of DRB3 would ensure that all animals
within herds would be protected.
Of course in terms of candidate genes for the vaccine
response to BRSV, it is unlikely that only the MHC  region
would be important. As we (Clapperton et al., 2009; Glass
et  al., 2010) have argued elsewhere, genes expressed in
the  innate immune system are strong candidate genes for
infectious  disease associated traits in livestock as (a) acti-
vation  of the innate immune system is essential and indeed
determines the nature of the acquired immune response,
(b)  the genes involved are present in the germ-line, are
highly  polymorphic and code for molecules involved in
the  initial interactions of pathogens and the host defence
system and (c) these molecules include pattern recogni-
tion  receptors and soluble molecules (PRR and PRM) that
sense  a wide range of pathogens. PRMs and PRRs inter-
act  with pathogen associated molecular patterns (PAMPs)
which are conserved on pathogens but generally not found
in  host species. The most well known PRRs are the Toll-like
receptors (TLRs), but more recently a number of other PRR
families  have been described including the RNA helicase-
type  retinoic acid-inducible gene-1 receptors (RIG-1-like
helicases) and NOD-like receptors which appear to be rel-
evant  for host detection of viruses (reviewed by Brennan
and  Bowie, 2010). Many candidate gene variants have been
associated with severe humans RSV infections including
PRMs – collectins, surfactant proteins A–D and mannose
binding lectin (MBL), and the PRRs – TLR4 and TLR8 (Janssenmmunopathology 148 (2012) 90– 99 95
et  al., 2007; Miyairi and DeVincenzo, 2008; Glass et al.,
2010).  Although TLR2, TLR3 and RIG-1 have all been impli-
cated  in host interactions with RSV, no genetic associations
in  human studies have been reported. In cattle, a number of
distinct  collectin genes form a cluster on BTA28 (Gjerstorff
et  al., 2004), and some have been associated with viral
pathogen interactions (Lillie et al., 2005). Polymorphisms
have been described in bovine MBL  (Wang et al., 2011) and
bovine  conglutinin levels are heritable (Holmskov et al.,
1998).  Similarly, bovine viral recognition TLRs (Cargill and
Womack,  2007), and NOD2 (also known as CARD15) har-
bour  polymorphisms (Taylor et al., 2006) and a single SNP
has  been reported in bovine RIG-1 (Cargill et al., 2006).
Some associations of TLR variants with bacterial but not
viral  diseases have been reported in cattle. We  have argued
that  TLRs and their intracellular down-stream signalling
components may  be the most likely candidates for many
infectious disease traits in livestock species (Jann et al.,
2009;  Werling et al., 2009). Furthermore, as adjuvants are
essential  to invoke responses to vaccine components by
triggering innate immunity, we  suggest that gene vari-
ants  encoding innate immune system proteins may  also
inﬂuence vaccine responsiveness. Although many SNPs in
candidate  genes have been proposed, very few studies in
livestock  have reported signiﬁcant associations and this
may  in some cases be because the SNPs have no functional
consequences. Determining whether individual SNPs are
functionally relevant requires complex molecular biology
and  we  have proposed that a simpler approach to nar-
row  down the candidates is to consider only those SNPs
that  are both non-synonymous and positively selected
(Jann et al., 2008). Of course this excludes SNPs that are
non-coding and we accept that it is likely that SNPs in pro-
moter  regions can change expression levels and therefore
could also have functional consequences. However even in
human  populations the relative importance of coding SNPs
and  non-coding SNPs in determining complex disease is as
yet  unknown, although it is clear that there is consider-
able inter-individual variation in gene expression across
the  human genome (Cookson et al., 2009; Skelly et al.,
2009). With the advent of massive parallel sequencing for
transcriptomics the contribution of inherited variation in
gene  expression to complex traits should become clearer
(Majewski and Pastinen, 2011).
However we  decided to test whether our proposal has
merit  and investigated whether any non-synonymous and
positively  selected SNPs in bovine TLRs were associated
with the response to the BRSV vaccine and also to the FMDV
peptide. In addition, the maximum number of microsatel-
lite markers per chromosome in the QTL study was six,
and  thus as discussed above large conﬁdence intervals
were obtained which contain hundreds of candidate genes.
Clearly  this limits both the power and accuracy of the study,
and  in order to narrow the regions, we  added additional
SNP markers within some of the QTL. We  found that a
number of SNPs on different chromosomes were signiﬁ-
cantly associated with the response to the BRSV vaccine
(Table 4) and also to the FMDV peptide (results not shown).
The  variance of the phenotypic trait accounted for by indi-
vidual  SNPs was  in general much higher than for the QTL
study,  with some explaining over 10% of the phenotypic
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Table  4
The  sequential inﬂuence of signiﬁcant SNPs associated with BRSV speciﬁc antibody levels at vaccination day and post-vaccination.
Traita Dayb Chromosome number (BTAc)
12 16 22 24 6 7 19 25 X 21 27 29 8
IgG2 0  Xd X X X
14 X X
35 X X X
49 X X
IgG1 14 X X X X
35 X X
49
Overalle IgG1 X
Overall IgG2 X
a Trait = BRSV speciﬁc antibody level, measured by ELISA as detailed in (O’Neill et al., 2006).
b Day is relative to vaccination at day 0.
c BTA = Bos taurus autosome. The order shown attempts to reﬂect the sequential inﬂuence of different SNP across the time course, with those loci which
inﬂuence  the response at the earliest time point being shown ﬁrst.
d Each X represents the presence of a signiﬁcant SNP (p < 0.05).
e Overall refers to the total amount of IgG isotype generated across time (calculated as “area under the curve” by the Trapezoidal rule).
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ver  as with the QTL study it is clear that both time and
sotype of antibody must be under different genetic con-
rol.  Although we tested for association of bovine SNPs in
ll  ten TLRs, we only found two associated with response
o  the BRSV vaccine. Of particular interest, one of the most
igniﬁcant SNPs was on BTA 8, which inﬂuenced the IgG1
nd  IgG2 response to the BRSV vaccine and was  located
ithin the TLR4 gene. Further analysis determined that
his  SNP was non-synonymous and positively selected. Two
urther  highly signiﬁcant non-synonymous and positively
elected SNPs were located in TLR8 and inﬂuenced the
esponse to both BRSV vaccine and also the FMDV pep-
ide.  It is possible that both TLR4 and TLR8 are involved intion in outcome following natural infection or vaccination with BRSV.
ovements in host disease resistance and/or vaccine efﬁcacy.
the  recognition of BRSV as there is evidence that HRSV F
protein  binds to TLR4 (Kurt-Jones et al., 2000) and BRSV
induces a TLR4-dependent NFkB response in bovine TLR
transfected cells (Lizundia et al., 2008). In addition TLR8
senses ssRNA and RSV is an RNA virus although no direct
interactions between TLR8 and RSV have been reported. In
humans  polymorphisms in TLR4 and TLR8 have been asso-
ciated  with severity of BRSV infection (Janssen et al., 2007).
5.  Concluding remarks
In  conclusion, genetics clearly inﬂuences both the
response to vaccination and also to infection. In addition,
genetics also plays a key role in the rate of clearance of
maternal antibody. Although we have identiﬁed a number
of  candidate variants, which include BoLA DRB3 and TLRs
4  and 8 as playing a signiﬁcant role, we have also identiﬁed
many regions that may  harbour novel genes that are
gy and IE.J. Glass et al. / Veterinary Immunolo
important in determining the response to vaccination.
Because of the strong linkage between genes in the BoLA
region,  we currently cannot disentangle whether our data
supports  the role of BoLA DRB3 or is linked to polymor-
phisms in other classical class II genes (DQA and/or DQB)
or  indeed class I genes. However, the pocket 4 associations
would strongly suggest that BoLA DRB3 is playing an
important role in the observed variation in antibody
response. We  and others have demonstrated the impor-
tance and complexity of DQ molecules in T cell responses
in  cattle (Glass et al., 2000; Norimine and Brown, 2005;
Gerner et al., 2009), and further exploration of the role of
DQ  in bovine responses to BRSV is warranted. We  found
three non-synonymous, positively selected SNPs in two
TLRs  providing some support to our hypotheses relating to
the  involvement of innate immune genes in disease resis-
tance  and vaccine responsiveness. The lack of evidence for
association  with SNPs in other candidate genes does not of
course  rule out a role for them, as it could simply be that the
study  was too small to detect their inﬂuence and/or other
polymorphisms may  not be represented in the study herd.
Although the uncertainty surrounding the correlates of
protection for BRSV remains to be solved, our initial studies
suggest  that another signiﬁcant factor in observed variation
in  protection and pathology following natural infection
and vaccination in cattle may  be host genetics. However,
in  order to investigate further, the QTL and SNPs require
validation in new and larger populations as well as more
detailed molecular studies, for example cells transfected
with different TLR variants may  reveal the underlying
mechanisms. Future studies that improve our understand-
ing of the role of genetics in immune responsiveness and
disease  resistance have the potential to improve vaccine
efﬁcacy as well as provide selectable markers that breeders
could  use to improve livestock disease resistance as well
as  vaccine responsiveness (Fig. 1).
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